Mohammed A. Khan

1.4k total citations · 1 hit paper
44 papers, 1.1k citations indexed

About

Mohammed A. Khan is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Mohammed A. Khan has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 11 papers in Hepatology and 7 papers in Infectious Diseases. Recurrent topics in Mohammed A. Khan's work include Hepatitis C virus research (11 papers), Escherichia coli research studies (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Mohammed A. Khan is often cited by papers focused on Hepatitis C virus research (11 papers), Escherichia coli research studies (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Mohammed A. Khan collaborates with scholars based in United States, Canada and Saudi Arabia. Mohammed A. Khan's co-authors include Bruce A. Vallance, Caixia Ma, Carrie M. Rosenberger, Theodore S. Steiner, Kirk Bergstrom, Yanet Valdez, Deanna L. Gibson, B. Brett Finlay, Jian Kang and Wanyin Deng and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Mohammed A. Khan

37 papers receiving 1.1k citations

Hit Papers

Universal Hepatitis B Vaccination in Adults Aged 19–59 Ye... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammed A. Khan United States 16 310 291 279 237 208 44 1.1k
Chris M. Parry United Kingdom 20 410 1.3× 190 0.7× 175 0.6× 645 2.7× 115 0.6× 42 1.3k
Ruth Berggren United States 10 183 0.6× 154 0.5× 151 0.5× 286 1.2× 220 1.1× 25 931
Pierre Guesry Switzerland 12 278 0.9× 142 0.5× 105 0.4× 222 0.9× 114 0.5× 24 1.0k
Margarita Ramírez Spain 13 305 1.0× 112 0.4× 75 0.3× 79 0.3× 129 0.6× 50 731
Ali Pirani United States 12 466 1.5× 681 2.3× 587 2.1× 390 1.6× 142 0.7× 29 1.6k
Merceditas Villanueva United States 16 299 1.0× 258 0.9× 203 0.7× 198 0.8× 46 0.2× 53 799
Kun-Yen Huang United States 18 290 0.9× 413 1.4× 138 0.5× 262 1.1× 108 0.5× 29 1.2k
Ramiro L. Gutiérrez United States 14 148 0.5× 59 0.2× 157 0.6× 364 1.5× 235 1.1× 46 712
Jae Seung Yang South Korea 18 157 0.5× 250 0.9× 157 0.6× 273 1.2× 253 1.2× 57 927
Michael A. Pazos United States 14 218 0.7× 425 1.5× 141 0.5× 159 0.7× 96 0.5× 15 889

Countries citing papers authored by Mohammed A. Khan

Since Specialization
Citations

This map shows the geographic impact of Mohammed A. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed A. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed A. Khan more than expected).

Fields of papers citing papers by Mohammed A. Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed A. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed A. Khan. The network helps show where Mohammed A. Khan may publish in the future.

Co-authorship network of co-authors of Mohammed A. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed A. Khan. A scholar is included among the top collaborators of Mohammed A. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed A. Khan. Mohammed A. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rankin, Danielle A., et al.. (2025). Changes in Carbapenemase-Producing Carbapenem-Resistant Enterobacterales, 2019 to 2023. Annals of Internal Medicine. 178(12). 1818–1821.
4.
Wu, Yan Yan, Mohammed A. Khan, George Hung, et al.. (2025). Evaluating the Reliability and Robustness of Racial and Ethnic Health Disparities in Cardiometabolic Disease in NHANES, NHIS, and BRFSS (2015–2021). Journal of the American Heart Association. 14(5). e040029–e040029.
5.
Khan, Mohammed A., W. Thompson, William A. Meyer, et al.. (2023). Testing for Hepatitis C During Pregnancy Among Persons With Medicaid and Commercial Insurance: Cohort Study. JMIR Public Health and Surveillance. 9. e40783–e40783.
6.
Khan, Mohammed A., Bonnie Bruce, Lyndsay Bottichio, & Matthew E. Wise. (2023). A Bayesian Method for Exposure Prevalence Comparison During Foodborne Disease Outbreak Investigations. Foodborne Pathogens and Disease. 20(9). 414–418. 1 indexed citations
7.
Kaufman, Harvey W., William A. Meyer, Mohammed A. Khan, et al.. (2022). Hepatitis C Virus Testing During Pregnancy After Universal Screening Recommendations. Obstetrics and Gynecology. 140(1). 99–101. 16 indexed citations
8.
Weng, Mark K., Mona Doshani, Mohammed A. Khan, et al.. (2022). Universal hepatitis B vaccination in adults aged 19–59 years: Updated recommendations of the advisory committee on immunization practices—United States, 2022. American Journal of Transplantation. 22(6). 1714–1720. 10 indexed citations
9.
Weng, Mark K., Mona Doshani, Mohammed A. Khan, et al.. (2022). Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022. MMWR Morbidity and Mortality Weekly Report. 71(13). 477–483. 110 indexed citations breakdown →
10.
Kaufman, Harvey W., Lara Bull–Otterson, William A. Meyer, et al.. (2021). Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic. American Journal of Preventive Medicine. 61(3). 369–376. 60 indexed citations
11.
Harris, Aaron M., et al.. (2021). Hepatitis C Treatment Among Commercially or Medicaid-Insured Individuals, 2014–2018. American Journal of Preventive Medicine. 61(5). 716–723. 10 indexed citations
12.
Hakami, Alqassem Y., et al.. (2021). Prevalence of Behavioral Addictions and Their Relationship With Stress and Anxiety Among Medical Students in Saudi Arabia: A Cross-Sectional Study. Frontiers in Psychiatry. 12. 727798–727798. 14 indexed citations
13.
Tsang, Clarisse A., et al.. (2019). Utilizing Electronic Laboratory Reporting Data to Assess the Burden of Hepatitis C in Arizona. Journal of Public Health Management and Practice. 26(6). 562–569. 2 indexed citations
14.
Jones, Jefferson M., Lia Koski, Mohammed A. Khan, et al.. (2017). Coccidioidomycosis: An underreported cause of death—Arizona, 2008–2013. Medical Mycology. 56(2). 172–179. 15 indexed citations
15.
Alshammari, Sulaiman, et al.. (2017). The burden perceived by informal caregivers of the elderly in Saudi Arabia. Journal of Family and Community Medicine. 24(3). 145–145. 32 indexed citations
16.
Ryan, Bríd M., Roger K. Wolff, Nicola Valeri, et al.. (2014). An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer. Cancer Epidemiology. 38(5). 583–590. 24 indexed citations
17.
Sutton, Troy C., Farnoosh Tayyari, Mohammed A. Khan, Heather Manson, & Richard G. Hegele. (2007). T Helper 1 Background Protects Against Airway Hyperresponsiveness and Inflammation in Guinea Pigs With Persistent Respiratory Syncytial Virus Infection. Pediatric Research. 61(5, Part 1). 525–529. 15 indexed citations
18.
Khan, Mohammed A., Jian Kang, & Theodore S. Steiner. (2004). Enteroaggregative Escherichia coli flagellin‐induced interleukin‐8 secretion requires Toll‐like receptor 5‐dependent p38 MAP kinase activation. Immunology. 112(4). 651–660. 71 indexed citations
20.
Khan, Mohammed A., et al.. (1990). Neuromyelitis optica (Devic's disease). International Journal of Clinical Practice. 44(12). 667–668. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026